Table 2.
All patients (n=121) | RP patients (n=21) | ||
---|---|---|---|
“unambiguous” (n=11) | “hard to score” (n= 10) | ||
Mean age (range, years) | 60 (39–86) | 65 (42–85) | 64 (47–85) |
Gender (male) | 76 (63%) | 7 (33%) | 6 (29%) |
Stage | |||
I | 8 (7%) | - | 3 (14%) |
II | 8 (7%) | 1 (5%) | 3 (14%) |
III | 105 (86%) | 10 (48%) | 4 (19%) |
Smoking history* | 109 (92%) | 10 (48%) | 9 (43%) |
Ongoing smoking* | 56 (47%) | 2 (10%) | 7 (33%) |
Primary tumor location | |||
Upper lobe | 91 (75%) | 7 (33%) | 8 (38%) |
Middle and/or lower lobe | 30 (25%) | 4 (19%) | 2 (95%) |
COPD history | 48 (40%) | 3 (14%) | 7 (33%) |
Pre-FEV1 <1.7 L ** | 50 (42%) | 5 (24%) | 8 (38%) |
Abbreviations: RP= radiation pneumonitis
Available in the 119 patients.
Using 1.7 L as a cut-point (the median value in our patients). Available in the 118 patients